News
Leading BioPharma consultancy SmartAnalyst appoints new CEO
SmartAnalyst, an Ashfield Advisory company, part of UDG Healthcare plc., has appointed Sasha Richardson as Chief Executive Officer.
With 24 years’ experience, most recently as a Managing Director and senior leader in Ernst and Young’s Health Sciences & Wellness practice,...
News
IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange platform with Polar, IDBS’ Biopharmaceutical Lifecycle Management platform
IDBS, a leading innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, a pioneer in laboratory IoT, have entered into a strategic partnership to create a combined solution that will significantly extend IDBS Polar BPLM’s laboratory data connectivity and instrument...
News
Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial
Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small molecule called ebselen.
The latest development comes after Sound Pharmaceuticals received a Cooperative Grant award worth $3.1m from the US National Institutes of Health (NIH)...
News
UK begins rollout of Moderna vaccine against COVID-19 in Wales
Moderna’s Covid-19 vaccine rollout has begun in the UK, where patients in Wales have been the first to receive a dose. Supplies arrived in Wales with 5,000 doses having been delivered to vaccination centres across Carmarthenshire, Ceredigion and Pembrokeshire....
News
Peli BioThermal Adds Module in School of Cool Online Learning Platform
Peli BioThermal, the global name in temperature controlled solutions, announces a new module available now on its School of Cool™ online learning platform. The newest module available in the platform introduces customers and distributors to reusable and single-use shippers,...
News
Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals
Hitachi, Ltd. announced that they have agreed on a comprehensive collaborative partnership to develop solutions contributing on more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery platform. Hitachi has also made investment to Drug Discovery Gateway...
News
AB Science and University of Chicago to develop Covid-19 drugs
AB Science SA, together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and treatment of humans infected with nidoviruses, coronaviruses and picornaviruses.
This collaboration follows the discovery by the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















